Upgrade to SI Premium - Free Trial

Q32 Bio (QTTB)

11.99 -0.81 (6.33%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Form 4 Q32 Bio Inc. For: Aug 25 Filed by: Violette Shelia M. August 27, 2026 4:10 PM - SEC Filing Form 4 Q32 Bio Inc. For: Aug 25 Filed by: Morrison Jodie Pope August 27, 2026 4:10 PM - SEC Filing Form 4 Q32 Bio Inc. For: Aug 25 Filed by: Kalowski Lee August 27, 2026 4:10 PM - SEC Filing Morgan Stanley Starts Q32 Bio Inc. (QTTB) at Overweight August 24, 2026 4:47 AM - StreetInsider Form SCHEDULE 13G/A Q32 Bio Inc. Filed by: Point72 Asset Management, L.P. August 14, 2026 4:16 PM - SEC Filing Form SCHEDULE 13G/A Q32 Bio Inc. Filed by: Sirenia Capital Management LP August 14, 2026 8:36 AM - SEC Filing Q32 Bio Inc. (QTTB) PT Lowered to $59 at Wells Fargo August 6, 2026 6:38 AM - StreetInsider Q32 Bio (QTTB) Tops Q2 EPS by 13c August 5, 2026 7:21 AM - StreetInsider Form 10-Q Q32 Bio Inc. For: Jun 30 August 5, 2026 7:10 AM - SEC Filing Form 8-K Q32 Bio Inc. For: Aug 05 August 5, 2026 7:03 AM - SEC Filing Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update August 5, 2026 6:59 AM - PR NewsWire Form SCHEDULE 13G/A Q32 Bio Inc. Filed by: Opaleye Management Inc. July 31, 2026 4:06 PM - SEC Filing Form EFFECT Q32 Bio Inc. July 29, 2026 6:08 AM - SEC Filing Form 424B3 Q32 Bio Inc. July 28, 2026 4:56 PM - SEC Filing Q32 Bio Inc. (QTTB) PT Raised to $36 at H.C. Wainwright July 28, 2026 6:00 AM - StreetInsider Form 4/A Q32 Bio Inc. For: Jun 12 Filed by: TZIANABOS ARTHUR July 21, 2026 8:40 PM - SEC Filing Form 4/A Q32 Bio Inc. For: Jun 12 Filed by: LAPORTE KATHLEEN July 21, 2026 8:39 PM - SEC Filing Form 4/A Q32 Bio Inc. For: Jun 12 Filed by: Lundberg Sven Ante July 21, 2026 8:39 PM - SEC Filing Form 4/A Q32 Bio Inc. For: Jun 12 Filed by: Iwicki Mark T July 21, 2026 8:38 PM - SEC Filing Form 4/A Q32 Bio Inc. For: Jun 12 Filed by: Xu Diyong July 21, 2026 8:26 PM - SEC Filing Form 4/A Q32 Bio Inc. For: Jun 12 Filed by: Manke Isaac July 21, 2026 8:25 PM - SEC Filing Form 4/A Q32 Bio Inc. For: Jun 12 Filed by: GRAYZEL DAVID S. July 21, 2026 8:24 PM - SEC Filing Form 4/A Q32 Bio Inc. For: Jun 12 Filed by: Thistle Mary July 21, 2026 8:23 PM - SEC Filing Form SCHEDULE 13D/A Q32 Bio Inc. Filed by: ORBIMED ADVISORS LLC July 20, 2026 9:33 PM - SEC Filing Form 4 Q32 Bio Inc. For: Jul 16 Filed by: Violette Shelia M. July 20, 2026 9:31 PM - SEC Filing Form 4 Q32 Bio Inc. For: Jul 16 Filed by: Morrison Jodie Pope July 20, 2026 9:28 PM - SEC Filing Form 4 Q32 Bio Inc. For: Jul 16 Filed by: Kalowski Lee July 20, 2026 9:26 PM - SEC Filing Q32 Bio (QTTB) files for 6.875M share offering by selling stockholders July 17, 2026 4:16 PM - StreetInsider Form S-3 Q32 Bio Inc. July 17, 2026 4:15 PM - SEC Filing Form 8-K Q32 Bio Inc. For: Jul 14 July 15, 2026 5:19 PM - SEC Filing Form 424B5 Q32 Bio Inc. July 15, 2026 5:11 PM - SEC Filing Q32 Bio prices $200 million stock offering at $18.25 per share July 14, 2026 10:59 PM - StreetInsider Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-Funded Warrants July 14, 2026 10:59 PM - PR NewsWire Form EFFECT Q32 Bio Inc. July 14, 2026 6:04 AM - SEC Filing Form 424B5 Q32 Bio Inc. July 13, 2026 4:47 PM - SEC Filing Q32 Bio launches $200M stock offering to fund clinical trials July 13, 2026 4:01 PM - StreetInsider Q32 Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants July 13, 2026 4:01 PM - PR NewsWire Q32 Bio Inc. (QTTB) PT Raised to $36 at Mizuho July 13, 2026 2:14 PM - StreetInsider Q32 Bio Inc. (QTTB) PT Raised to $36 at Mizuho July 13, 2026 2:09 PM - StreetInsider Wells Fargo Upgrades Q32 Bio Inc. (QTTB) to Overweight July 13, 2026 10:58 AM - StreetInsider Q32 Bio Inc. (QTTB) PT Raised to $40 at Oppenheimer July 13, 2026 9:32 AM - StreetInsider Form 8-K Q32 Bio Inc. For: Jul 13 July 13, 2026 8:40 AM - SEC Filing Form 8-K Q32 Bio Inc. For: Jul 13 July 13, 2026 7:10 AM - SEC Filing Q32 Bio reports Phase 2a trial results for alopecia areata drug July 13, 2026 6:59 AM - StreetInsider Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata July 13, 2026 6:59 AM - PR NewsWire Form SCHEDULE 13G Q32 Bio Inc. Filed by: Boxer Capital Management, LLC July 10, 2026 4:35 PM - SEC Filing Q32 Bio to release alopecia areata trial data on July 13 July 10, 2026 4:06 PM - StreetInsider Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026 July 10, 2026 4:05 PM - PR NewsWire Form SCHEDULE 13G/A Q32 Bio Inc. Filed by: Carlyle Group Inc. July 6, 2026 7:20 PM - SEC Filing Form 4 Q32 Bio Inc. For: Jun 30 Filed by: Manke Isaac July 2, 2026 4:31 PM - SEC Filing Q32 Bio (QTTB) files $300M mixed shelf June 25, 2026 4:15 PM - StreetInsider Form S-3 Q32 Bio Inc. June 25, 2026 4:12 PM - SEC Filing Form 4 Q32 Bio Inc. For: Jun 12 Filed by: Iwicki Mark T June 16, 2026 4:31 PM - SEC Filing Form 4 Q32 Bio Inc. For: Jun 12 Filed by: Manke Isaac June 16, 2026 4:31 PM - SEC Filing Form 4 Q32 Bio Inc. For: Jun 12 Filed by: TZIANABOS ARTHUR June 16, 2026 4:31 PM - SEC Filing Form 4 Q32 Bio Inc. For: Jun 12 Filed by: LAPORTE KATHLEEN June 16, 2026 4:31 PM - SEC Filing Form 4 Q32 Bio Inc. For: Jun 12 Filed by: GRAYZEL DAVID S. June 16, 2026 4:31 PM - SEC Filing Form 4 Q32 Bio Inc. For: Jun 12 Filed by: Xu Diyong June 16, 2026 4:31 PM - SEC Filing Form 4 Q32 Bio Inc. For: Jun 12 Filed by: Thistle Mary June 16, 2026 4:31 PM - SEC Filing Form 4 Q32 Bio Inc. For: Jun 12 Filed by: Lundberg Sven Ante June 16, 2026 4:31 PM - SEC Filing Form 8-K Q32 Bio Inc. For: Jun 12 June 16, 2026 4:02 PM - SEC Filing Full Article List